| Hazard Information | Back Directory | [Description]
LY-510929, also known as LY-929, is a peroxisome proliferator-activated receptor (PPAR) agonist potentially for the treatment of hyperlipidaemia, metabolic disorders and type 2 diabetes. | [Uses]
LY-510929 is a compound that induces left ventricular hypertrophy (LVH). Related studies have identified the relevant conditions in which LY-510929 may induce LVH by measuring multiple markers and using multiple techniques. | [References]
[1] The application of comparative molecular field analysis for the design of α-anilino substituted-3-phenyl propanoic acids as novel PPARα/γ dual ligands |
|
|